Occam Places Gurpreet Ratra as CBO at Skyline
Skyline Therapeutics, an F-Prime/Eight Roads investment, is a cell & gene therapy company developing novel genetic medicines across multiple therapeutic areas for global markets. The company has extensive R&D and manufacturing operations in Shanghai and affiliate offices in the U.S.
In August 2020, Occam recruited Gurpreet Ratra, PhD as the company’s CBO. Prior to joining Skyline, Gurpreet served as Head of Business Development at Spark Therapeutics.
Occam Global is an international life science executive search and leadership advisory firm dedicated to building management teams for innovative companies in the biotech, techbio, life sciences, and venture capital sectors. Our firm’s unique strength lies in our seamless access to elite talent, proven expertise in aligning exceptional business and scientific leaders with optimal opportunities, and a steadfast dedication to creating meaningful industry impact, guided by elevated ethics and enlightened aggression. Trusted by entrepreneurs, investors, and corporations worldwide, Occam Global is recognized as the premier partner for executive search and recruitment in the life sciences. Our success is rooted in establishing trust, cultivating and valuing relationships, and committing to serve as forthright and good-humored partners in realizing extraordinary ambitions.